Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Bowker

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The Journal of Infection|November 20, 1998
Sequential antimicrobial therapy: pharmacokinetic and pharmacodynamic considerations in sequential therapyA P MacGowan, K E Bowker
Clinical Pharmacokinetics|December 5, 1998
Continuous infusion of beta-lactam antibioticsA P MacGowan, K E Bowker
Journal of Chemotherapy (Florence, Italy)|May 1, 1997
Pharmacodynamics of antimicrobial agents and rationale for their dosingA P MacGowan, K E Bowker
International Journal of Antimicrobial Agents|December 9, 2003
In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogensK E Bowker, A R Noel, A P MacGowan
The Journal of Antimicrobial Chemotherapy|February 28, 2002
BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobialsM Wootton, K E Bowker, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patientsK E Bowker, M Wootton, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2019
Pharmacodynamics of aztreonam against Escherichia coli and Klebsiella oxytoca: defining pharmacodynamic targetsA R Noel, M Attwood, K E Bowker, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2021
The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infectionA R Noel, M Attwood, K E Bowker, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and GA P MacGowan, K E Bowker, M Wootton, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infectionA P MacGowan, K E Bowker, M Wootton, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Infection|November 20, 1998
Sequential antimicrobial therapy: pharmacokinetic and pharmacodynamic considerations in sequential therapyA P MacGowan, K E Bowker
Clinical Pharmacokinetics|December 5, 1998
Continuous infusion of beta-lactam antibioticsA P MacGowan, K E Bowker
Journal of Chemotherapy (Florence, Italy)|May 1, 1997
Pharmacodynamics of antimicrobial agents and rationale for their dosingA P MacGowan, K E Bowker
International Journal of Antimicrobial Agents|December 9, 2003
In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogensK E Bowker, A R Noel, A P MacGowan
The Journal of Antimicrobial Chemotherapy|February 28, 2002
BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobialsM Wootton, K E Bowker, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|February 28, 2002
In vitro activity of linezolid against Gram-positive isolates causing infection in continuous ambulatory peritoneal dialysis patientsK E Bowker, M Wootton, H A Holt, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2019
Pharmacodynamics of aztreonam against Escherichia coli and Klebsiella oxytoca: defining pharmacodynamic targetsA R Noel, M Attwood, K E Bowker, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2021
The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infectionA R Noel, M Attwood, K E Bowker, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and GA P MacGowan, K E Bowker, M Wootton, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infectionA P MacGowan, K E Bowker, M Wootton, et al.
Pageof 5